Shah, M. A., Cho, J., Tan, I. B., Tebbutt, N. C., Yen, C., Kang, A., . . . Kang, Y. (2016). A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction. Oncologist.

Shah, Manish A., Jae-Yong Cho, Iain B. Tan, Niall C. Tebbutt, Chia-Jui Yen, Alice Kang, David S. Shames, Lilian Bu, and Yoon-Koo Kang. "A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction." Oncologist 2016.

Shah, Manish A., et al. "A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction." Oncologist 2016.